QPS

18 articles about QPS

• QPS Supports COVID-19 Vaccine Development In Taiwan

  7/30/2021

  QPS, a global contract research organization focused on bioanalytics and clinical trials, is honored to have collaborated with Medigen Vaccine Biologics Corporation to complete toxicology studies necessary for the development of a COVID-19 vaccine.

• QPS Awarded Two 2020 CRO Leadership Awards

  6/2/2020

  QPS is a GLP/GCP-compliant and CLIA-certified contract research organization delivering discovery, preclinical, and clinical drug development services since 1995.

• QPS Continues to Expand UPLC-HRMS Quantitation Capabilities to Support Gene Therapy and Protein Drug Development

  5/19/2020

  QPS, a global contract research organization that provides discovery, preclinical, and clinical drug development services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics.

• QPS Announces Novel Coronavirus/COVID-19 Testing Capability

  5/12/2020

  QPS, a global contract research organization that provides GLP-compliant discovery, preclinical, and clinical drug development services, announces a newly developed capability to conduct COVID-19 testing, available as of Monday, May 11, 2020.

• QPS Expands Its Global Footprint With New Facilities In The Netherlands, India, And China

  9/18/2019

  QPS, a leading contract research organization, continues to expand its global footprint with new clinics in the Netherlands and India and a new bioanalytical facility in China.

• QPS Announces Continuing Growth in Asia, Hosts 28 Taiwanese Delegates at Delaware Headquarters

  6/18/2019

  QPS announced continuing growth in Asia, a region that is fast becoming a robust biotech and pharmaceutical research hub.

• QPS Announces 170 Percent Revenue Growth For In Vitro Studies Across Europe

  5/20/2019

  More than half of in vitro clients moving to perform follow-on in vivo studies with the company. 

• QPS Announces Launch of New Brand Identity, Celebrates 24 Years of Growth

  1/8/2019

  The year 2019 marks 24 years of growth for QPS, LLC, the company announced the launch of a new brand identity to support continued global expansion.

• QPS Expands U.S.-Based Phase I Clinical Trial Capabilities to Support the Growing Needs of Its Pharmaceutical, Biotechnology and CRO Partners

  11/27/2018

  QPS, a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development, today announced the expansion of its U.S.-based Phase I clinical trial capabilities to support the growing needs of its pharmaceutical, biotechnology and CRO partners.

• QPS, LLC Expands Clinical Trial Services with Acquisition of Qualitix

  3/8/2011

• QPS, LLC Expands Phase 1 and Bioanalytical Capability by Acquisition of BioServe, India

  1/26/2011

• QPS, LLC Announces the Acquisition of Xendo Drug Development

  7/26/2010

• QPS, LLC Announces New Fellow of Autoradiography

  4/6/2010

• QPS Taiwan Awarded the First and Only GLP-Laboratory Certification by DOH, Taiwan

  9/17/2009

• QPS, LLC Forms Strategic Alliance with Taiwan's Development Center for Biotechnology

  7/7/2009

• Company Profile for QPS, LLC

  6/26/2009

• QPS, LLC Closes Acquisition of Bio-Kinetic Clinical Applications, Inc.

  2/28/2008

• QPS, LLC Announces Signing Agreement to Acquire Bio-Kinetic Clinical Applications, Inc., Gaining Phase I and Early Clinical Services

  12/6/2007